Sequenom and Former CFO Resolve Litigation
March 21, 2014
SAN DIEGO -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative diagnostic testing and genetic analysis solutions, today announced a resolution of litigation between the Company and Paul Hawran. Mr. Hawran served as the Company's Chief Financial Officer from April 2007 until September 2009. Mr. Hawran resigned in September 2009. After September 2009, [...]
RURO is Pleased to Announce New, Lower Pricing On SmartFreezer® 2.0
March 21, 2014
Frederick, Maryland -- Today, SmartFreezer® is still the only robotic, fully automated, LN2 freezer. SmartFreezer® has also established itself to be a top choice as an automated frozen storage solution, LN2 or not, for its excellent ratio of physical footprint to storage capacity to price – which is now even lower. RURO’s sample management software, [...]
March 20, 2014
Schlieren, Switzerland and Rockville, Maryland -- InSphero AG today announced a collaboration with the National Institutes of Health’s (NIH) National Center for Advancing Translational Sciences (NCATS) to identify anti-cancer agents with cytotoxic activity in 3D culture models. The project includes development of multi-cell type spheroids (MCTS) by InSphero in the company’s 96- and 384-well GravityPLUS™ [...]
March 20, 2014
New York, NY -- Using a shared-risk funding model has allowed technology suppliers, Pharma companies and other Life Sciences R&D organisations to work closely together to develop bespoke software tools while minimising financial risk. With multiple Pharma and other Life Sciences R&D organisations buying into a similar solution, there is the potential to reach a [...]
Accelrys Science Council Adds Three New Fellows Supporting Scientific Research and Innovation
March 20, 2014
SAN DIEGO -- Accelrys, Inc. (NASDAQ: ACCL), a leading provider of scientific innovation lifecycle management software and solutions, today announced the appointment of Accelrys employees Johan Carlsson, Anne Goupil-Lamy and Kate Lusczakoski as Fellows on the Accelrys Science Council. Carlsson, Goupil-Lamy and Lusczakoski respectively bring to the Council in-depth knowledge and experience in materials modelling, [...]
March 20, 2014
CHALFONT ST. GILES, UK and WALTHAM, MA, USA –– GE Healthcare Life Sciences, (NYSE: GE), and NetBio announced today that an extensive developmental validation of DNAscan™ Rapid DNA Analysis™ System has commenced. The studies will evaluate the overall system from swab-in to profile-out, including the instrument, NetBio BioChipSet™ Cassette, STR chemistry, and data interpretation by [...]
March 20, 2014
Beijing, China, and Hilden, Germany — QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced the commercial launch in China of its QuantiFERON®-TB Gold In-Tube (QuantiFERON-TB), the pioneering blood test that accurately identifies people infected with Mycobacterium tuberculosis, the bacterium that causes tuberculosis (TB). QuantiFERON-TB has become the test of choice around the world [...]
Nanounity and HybriScan Technologies Complete Agreement to Distribute SEM Raman Products
March 20, 2014
Santa Clara, CA -- Nanounity announces that it has entered into an agreement with HybriScan Technologies to distribute their Raman spectrometer designed for scanning electron microscopes (SEM). SEM Raman is a powerful combination of technologies providing high-resolution imaging and identification of chemical composition. The HybriScan Molecular Microscope (HSCMM) is a Raman microscope specifically developed to [...]
BioFire Defense NGDS Contract Award
March 20, 2014
Salt Lake City, UT -- BioFire Defense, LLC of Salt Lake City, UT announced today that it was awarded the Next Generation Diagnostic System (NGDS) Technology Development contract by the US Department of Defense (DoD) after 12 months of competitive prototyping. The 8 year $240M biodefense program is managed by the Joint Program Executive Office’s [...]
SQI Diagnostics Signs Commercial Agreement with Global Pharma Customer
March 19, 2014
Toronto, Ontario -- SQI Diagnostics Inc. (TSX-V: SQD), a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced that it has expanded its previously announced product development relationship with a global pharmaceutical company (“Global Pharma 1”) to develop a custom multiplex test to support the [...]
